Annual General Shareholders’ Meeting 2025 – Expected to be held on: June 5, 2025 - 2nd call / June 4, 2025 - 1st call
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality and safety standards, have contributed to a healthier and more sustainable society.
CHRONOS-PD: Plasma Science in Parkinson’s Research
Seeking early biological signs of disease.
Latest news
Grifols receives FDA clearance of IND application for Phase 2 trial of immunoglobulin drops for dry eye disease
Grifols delivers strong results across the board, increasing revenues by 7.4%, Adj EBITDA by 14.2% and improving free cash flow by EUR 209m
Grifols partners with IBL International to develop advanced biomarker panels for unique clinical diagnostics platform
Commitment to people and the planet
Aligned with the United Nations plan to achieve the Sustainable Development Goals defined in its 2030 Agenda, we work every day to do more and do better to contribute to the health and quality of life of people around the world.
The patients we serve are able to lead better lives. Patients inspire the work we do every day.
Scientific innovation at work
Our deep and expanding knowledge of plasma and the life sciences is helping us better understand human health and research potential treatments to improve it.
Get to know us
Our history
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded a clinical analysis laboratory in Barcelona, the precursor to Laboratorios Grifols.
Company
Grifols' mission, to improve people's health and well-being, has patients, donors and society at the heart of everything we do.
Careers
Would you like to make a positive impact on the lives of others? Join our team!
Lifegiving plasma
Our innovative medicines made from human plasma enable millions of patients with chronic and rare diseases to lead more fulfilling lives.